LONDON--(BUSINESS WIRE)--
FORM 8.3
Amendment to sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 16 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long |
Short |
||||
Number |
(%) |
Number |
(%) |
||
(1) |
Relevant securities |
|
|
|
|
1,808,216 |
1.40% |
181,861 |
0.14% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
132,935 |
0.10% |
7,066 |
0.01% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 |
0.00% |
6,100 |
0.00% |
|
|
|
|
|
||
(4) |
TOTAL: |
|
|
|
|
1,947,251 |
1.51% |
195,027 |
0.15% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities |
Price per unit |
Purchase | 1 |
221.5400 USD |
Purchase | 3 |
220.0466 USD |
Purchase | 4 |
220.0550 USD |
Purchase | 5 |
220.7300 USD |
Purchase | 5 |
220.5640 USD |
Purchase | 8 |
220.7662 USD |
Purchase | 9 |
220.5866 USD |
Purchase | 9 |
220.8222 USD |
Purchase | 11 |
220.6040 USD |
Purchase | 14 |
220.4207 USD |
Purchase | 15 |
220.0000 USD |
Purchase | 16 |
220.7896 USD |
Purchase | 18 |
221.1000 USD |
Purchase | 19 |
221.5384 USD |
Purchase | 26 |
221.1836 USD |
Purchase | 31 |
220.7800 USD |
Purchase | 40 |
219.9900 USD |
Purchase | 100 |
220.7000 USD |
Purchase | 100 |
220.6900 USD |
Purchase | 106 |
220.2700 USD |
Purchase | 137 |
220.7708 USD |
Purchase | 153 |
220.7320 USD |
Purchase | 173 |
219.8652 USD |
Purchase | 186 |
219.9600 USD |
Purchase | 200 |
219.6100 USD |
Purchase | 200 |
220.9158 USD |
Purchase | 802 |
222.0620 USD |
Purchase | 965 |
219.9321 USD |
Purchase | 1,276 |
219.8923 USD |
Purchase | 1,350 |
220.4392 USD |
Purchase | 1,935 |
220.0450 USD |
Purchase | 2,151 |
222.1000 USD |
Purchase | 2,373 |
221.0699 USD |
Purchase | 2,557 |
221.2621 USD |
Purchase | 3,341 |
219.8990 USD |
Purchase | 3,560 |
219.6365 USD |
Purchase | 3,987 |
219.9806 USD |
Purchase | 4,300 |
220.5017 USD |
Purchase | 7,536 |
222.0994 USD |
Purchase | 10,210 |
221.5958 USD |
Purchase | 14,959 |
222.0602 USD |
Purchase | 33,099 |
220.5778 USD |
Sale | 1 |
219.4800 USD |
Sale | 17 |
220.4900 USD |
Sale | 17 |
220.0000 USD |
Sale | 17 |
219.8200 USD |
Sale | 100 |
219.9100 USD |
Sale | 100 |
219.4700 USD |
Sale | 100 |
219.2900 USD |
Sale | 141 |
219.6376 USD |
Sale | 182 |
219.4642 USD |
Sale | 210 |
222.4190 USD |
Sale | 581 |
220.8500 USD |
Sale | 930 |
221.8987 USD |
Sale | 1,549 |
219.8075 USD |
Sale | 1,570 |
219.5540 USD |
Sale | 1,734 |
220.7999 USD |
Sale | 1,773 |
221.0009 USD |
Sale | 3,070 |
220.9908 USD |
Sale | 3,200 |
219.9105 USD |
Sale | 4,500 |
220.5201 USD |
Sale | 5,626 |
221.8673 USD |
Sale | 8,310 |
219.9800 USD |
Sale | 9,219 |
221.6654 USD |
Sale | 15,055 |
220.6007 USD |
Sale | 18,430 |
220.5424 USD |
Sale | 19,844 |
222.1000 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 18 Mar 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative |
|
|
|
||
relates |
|
|
|
||
Put Options | Purchased | -100 |
220.0000 |
American |
Jul 16, 2021 |
Call Options | Purchased | 100 |
240.0000 |
American |
Jul 16, 2021 |
Call Options | Purchased | 6,000 |
220.0000 |
American |
Jul 16, 2021 |
Put Options | Purchased | -6,000 |
200.0000 |
American |
Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.